It only takes one drug to produce massive returns, as Seattle Genetics (NASDAQ:SGEN), Medivation (NASDAQ:MDVN), and Regeneron Pharmaceuticals (NASDAQ:REGN) have shown. Click on the slideshow below to learn more about their drugs, and find three more companies that are hoping to become one-drug wonders this year.
- Jan 31, 2014 at 6:30PM
- Health Care
- 3 Most Profitable Drugmakers in the S&P 500 -- Are They Buys?
- Regeneron Pharmaceuticals Inc (REGN) Q4 2018 Earnings Conference Call Transcript
- 3 Top Biotech Stocks to Buy Right Now
- Biotech Stocks Made Big Progress Toward Preventing Heart Attacks in 2018
- Is It Too Late to Get In on This Millionaire-Maker Stock?